Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy B Niewold

Showing results (141-150 of 181) with videos related to

Pageof 19
Sort By:
Gut|February 4, 2015
The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferonWesley A Grimm, Jeannette S Messer, Stephen F Murphy, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 22, 2018
Pathogenic Citrulline-Multispecific B Cell Receptor Clades in Rheumatoid ArthritisPhilip J Titcombe, Gustaf Wigerblad, Natalie Sippl, et al.
Autoimmunity Reviews|January 25, 2025
Neuropsychiatric manifestations in systemic lupus erythematosus and Sjogren's diseaseAmanda Carolina Miranda Costa, Nunes Dpf, Paulo Rogério Júlio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2011
Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patientsTalin Robinson, Silvia N Kariuki, Beverly S Franek, et al.
Annals of the Rheumatic Diseases|June 11, 2016
Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosusKendra A Young, Melissa E Munroe, Joel M Guthridge, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
CD11b suppresses TLR7-driven inflammatory signaling to protect against lupus nephritisXiaobo Li, Veronica Villanueva, Viviana Jimenez, et al.
Immunity|January 16, 2020
Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus ErythematosusScott A Jenks, Kevin S Cashman, Esther Zumaquero, et al.
Immunity|October 14, 2018
Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus ErythematosusScott A Jenks, Kevin S Cashman, Esther Zumaquero, et al.
Annals of the Rheumatic Diseases|November 8, 2015
Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritisTheresa Wampler Muskardin, Priyanka Vashisht, Jessica M Dorschner, et al.
Annals of the Rheumatic Diseases|November 18, 2011
IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosusTimothy B Niewold, Jennifer A Kelly, Silvia N Kariuki, et al.
Pageof 19

Showing results (141-150 of 181) with videos related to

Sort By:
Pageof 19
Gut|February 4, 2015
The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferonWesley A Grimm, Jeannette S Messer, Stephen F Murphy, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 22, 2018
Pathogenic Citrulline-Multispecific B Cell Receptor Clades in Rheumatoid ArthritisPhilip J Titcombe, Gustaf Wigerblad, Natalie Sippl, et al.
Autoimmunity Reviews|January 25, 2025
Neuropsychiatric manifestations in systemic lupus erythematosus and Sjogren's diseaseAmanda Carolina Miranda Costa, Nunes Dpf, Paulo Rogério Júlio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2011
Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patientsTalin Robinson, Silvia N Kariuki, Beverly S Franek, et al.
Annals of the Rheumatic Diseases|June 11, 2016
Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosusKendra A Young, Melissa E Munroe, Joel M Guthridge, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
CD11b suppresses TLR7-driven inflammatory signaling to protect against lupus nephritisXiaobo Li, Veronica Villanueva, Viviana Jimenez, et al.
Immunity|January 16, 2020
Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus ErythematosusScott A Jenks, Kevin S Cashman, Esther Zumaquero, et al.
Immunity|October 14, 2018
Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus ErythematosusScott A Jenks, Kevin S Cashman, Esther Zumaquero, et al.
Annals of the Rheumatic Diseases|November 8, 2015
Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritisTheresa Wampler Muskardin, Priyanka Vashisht, Jessica M Dorschner, et al.
Annals of the Rheumatic Diseases|November 18, 2011
IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosusTimothy B Niewold, Jennifer A Kelly, Silvia N Kariuki, et al.
Pageof 19